You are about to leave www.astellas.com and enter a third-party website. Astellas is not responsible for the content or services on the third-party website.
Would you like to continue?
Advancing drug discovery for future breakthroughs
Astellas is at the forefront of innovation – pioneering cutting-edge technologies and developing proprietary platforms specifically designed to identify promising drug candidates and develop them into valuable assets. Our unwavering commitment empowers us to tackle unmet medical needs and drive advancements in healthcare.
We are focused on developing a state-of-the-art research environment with the latest technologies and proprietary research platforms. By leveraging them, our team of researchers are actively pursuing new targets and drug candidates with the goal to expedite the creation of new drugs and the enhance the probability of success.
Our key initiatives include:
Astellas is also building capabilities in the field of translational research, which helps to convert the findings in non-clinical studies into clinical outcomes in humans. This approach accelerates the drug discovery process and increases the probability of success.
Our key initiatives include:
Quantitative Systems Pharmacology (QSP): A mathematical modeling approach that integrates biological mechanisms to predict drug responses in humans
Please click below to learn more about recent research activities.